Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

BD: Medication Management Platform

BD (Becton, Dickinson and Company), a global medical technology company, recently launched a new software application designed to help hospitals and health systems identify drug diversion.

BD (Becton, Dickinson and Company, a global medical technology company, recently launched a new software application designed to help hospitals and health systems identify drug diversion.
BD (Becton, Dickinson and Company, a global medical technology company, recently launched a new software application designed to help hospitals and health systems identify drug diversion.

Addiction to prescription narcotics in the U.S. has reached epidemic proportions, contributing to the opioid crisis and becoming a major driver of drug diversion within healthcare settings. Diversion of drugs, for personal use or illegal distribution, can cause significant financial loss4 and potentially impact care to patients and staff safety.

As part of the BD HealthSight™ platform designed to support enterprise-wide medication management, the new BD HealthSight™ diversion management application is the next step in the company’s efforts to address drug diversion through integrated solutions and analytics. The product leverages data from existing BD products, including the BD Pyxis™ ES system, and the Electronic Medical Record (EMR) to provide actionable insights to assist with a hospital or health system’s diversion investigations.

Medication diversion is a growing and complex challenge for hospitals and health systems, requiring a holistic approach to medication management that includes a combination of connected technologies and robust analytics. Specific cases of diversion can be difficult to detect, and the impact can be devastating from a patient and healthcare worker safety standpoint. The new BD HealthSight diversion management application is designed to address the unique challenges associated with diversion by tracking patterns and risky behavior to help identify diverters as early as possible.”

BD HealthSight diversion management is a hosted, cloud-based application that assists with drug diversion investigations by creating an investigation workflow to monitor, triage and assign potential diversion cases to specific investigators. Compared to traditional, statistically based analytical tools that only look at amounts dispensed to identify potential diversion, BD utilizes machine learning algorithms and multiple dispensing behaviors, such as overrides, canceled transactions, delays in dispensing, administering and wasting medications, to surface clinicians whose behavior indicates higher risk for diversion.

BD has partnered with Microsoft, which brings industry leading expertise in artificial intelligence (AI) and data science methodologies, to support development of these machine-learning based algorithms. The application also aggregates EMR and dispensing cabinet data to automate a normally time-consuming and tedious manual review process to reconcile and automatically flag anomalous dispense, administration and waste transactions.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?